A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118 (IDP-118)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01670513
Recruitment Status : Unknown
Verified April 2013 by Dow Pharmaceutical Sciences.
Recruitment status was:  Active, not recruiting
First Posted : August 22, 2012
Last Update Posted : April 25, 2013
Information provided by (Responsible Party):
Dow Pharmaceutical Sciences

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2013
  Estimated Study Completion Date : July 2013